DNMT3A was expressed in 3% (2/79) of seminomas and 36% (37/102) of synovial sarcomas, while DNMT3B was expressed in 33% (27/79) of seminomas and 5% (5/102) of synovial sarcomas (Figure 4C,D). The gene discussed is DNMT3A; the disease is seminoma.